Prima BioMed Ltd. is a biotechnology company focused on researching and commercializing licensed medical products throughout Australia. Its immunotherapy products include oncology therapies, and its current lead product is a cancer vaccine for patients in remission. Other products include its oral vaccine against human papilloma virus, which may lead to cervical cancer in women. For more information, please visit www.primabiomed.com.au.